BFR35AP NPN Silicon RF Transistor * For low distortion broadband amplifiers and oscillators up to 2GHz at collector currents 2 3 from 0.5mA to 20 mA 1 ESD (Electrostatic discharge) sensitive device, observe handling precaution! Type BFR35AP Marking GEs Pin Configuration 1=B 2=E 3=C Package SOT23 Maximum Ratings Parameter Symbol Value Unit Collector-emitter voltage VCEO 15 Collector-emitter voltage VCES 20 Collector-base voltage VCBO 20 Emitter-base voltage VEBO 2.5 Collector current IC 45 Base current IB 4 Total power dissipation1) Ptot 280 mW Junction temperature Tj 150 C Ambient temperature TA -65 ... 150 Storage temperature T stg -65 ... 150 V mA TS 48C Thermal Resistance Parameter Symbol Value Unit Junction - soldering point 2) RthJS 365 K/W 1T is measured on the collector lead at the soldering point to the pcb S 2For calculation of R thJA please refer to Application Note Thermal Resistance 1 2005-10-13 BFR35AP Electrical Characteristics at TA = 25C, unless otherwise specified Symbol Parameter Values Unit min. typ. max. 15 - - V ICES - - 10 A ICBO - - 100 nA IEBO - - 100 A hFE 70 100 140 - DC Characteristics Collector-emitter breakdown voltage V(BR)CEO IC = 1 mA, I B = 0 Collector-emitter cutoff current VCE = 20 V, VBE = 0 Collector-base cutoff current VCB = 10 V, I E = 0 Emitter-base cutoff current VEB = 2.5 V, IC = 0 DC current gainIC = 15 mA, VCE = 8 V, pulse measured 2 2005-10-13 BFR35AP Electrical Characteristics at TA = 25C, unless otherwise specified Symbol Values Unit Parameter min. typ. max. AC Characteristics (verified by random sampling) Transition frequency fT 3.5 5 - Ccb - 0.39 0.55 Cce - 0.23 - Ceb - 0.64 - GHz IC = 15 mA, VCE = 8 V, f = 500 MHz Collector-base capacitance pF VCB = 10 V, f = 1 MHz, VBE = 0 , emitter grounded Collector emitter capacitance VCE = 10 V, f = 1 MHz, VBE = 0 , base grounded Emitter-base capacitance VEB = 0.5 V, f = 1 MHz, VCB = 0 , collector grounded Noise figure dB F IC = 2 mA, VCE = 6 V, ZS = ZSopt, f = 900 MHz - 1.4 - f = 1.8 GHz - 2 - ZL = ZLopt, f = 900 MHz - 16 - f = 1.8 GHz - 10.5 - Power gain, maximum available1) G ma IC = 15 mA, VCE = 8 V, Z S = ZSopt, |S 21e|2 Transducer gain dB IC = 15 mA, VCE = 8 V, Z S = Z L = 50, f = 900 MHz - 13 - f = 1.8 GHz - 7.5 - 1G 2 1/2 ma = |S21/S12| (k-(k -1) ) 3 2005-10-13 Package SOT23 BFR35AP 0.4 +0.1 -0.05 1) 2 0.08...0.1 C 0.95 1.3 0.1 1 2.4 0.15 3 0.1 MAX. 10 MAX. B 1 0.1 10 MAX. 2.9 0.1 0.15 MIN. Package Outline A 5 0...8 1.9 0.2 0.25 M B C M A 1) Lead width can be 0.6 max. in dambar area Foot Print 0.8 1.2 0.9 1.3 0.9 0.8 Marking Layout 12 s Date code (Year/Month) Pin 1 EH s Type code 37 Manufacturer 2003, July BCW66 Example Standard Packing Reel o180 mm = 3.000 Pieces/Reel Reel o330 mm = 10.000 Pieces/Reel 4 0.2 8 2.13 2.65 0.9 Pin 1 1.15 3.15 4 2005-10-13 BFR35AP Published by Infineon Technologies AG, St.-Martin-Strasse 53, 81669 Munchen (c) Infineon Technologies AG 2005. All Rights Reserved. Attention please! The information herein is given to describe certain components and shall not be considered as a guarantee of characteristics. Terms of delivery and rights to technical change reserved. We hereby disclaim any and all warranties, including but not limited to warranties of non-infringement, regarding circuits, descriptions and charts stated herein. Information For further information on technology, delivery terms and conditions and prices please contact your nearest Infineon Technologies Office (www.Infineon.com). Warnings Due to technical requirements components may contain dangerous substances. For information on the types in question please contact your nearest Infineon Technologies Office. Infineon Technologies Components may only be used in life-support devices or systems with the express written approval of Infineon Technologies, if a failure of such components can reasonably be expected to cause the failure of that life-support device or system, or to affect the safety or effectiveness of that device or system. Life support devices or systems are intended to be implanted in the human body, or to support and/or maintain and sustain and/or protect human life. If they fail, it is reasonable to assume that the health of the user or other persons may be endangered. 5 2005-10-13